Screener
Surgery Partners, Inc. SGRY Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures.
The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001638833-26-000077
| Line item | (Unaudited) / June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 1,126.0 | 1,150.7 |
| Property and equipment, net of accumulated depreciation of $718.0 and $651.2, respectively | 1,122.7 | 1,153.4 |
| Goodwill and other intangible assets, net | 5,242.1 | 5,235.6 |
| Investments in and advances to affiliates | 226.9 | 234.0 |
| Right-of-use operating lease assets | 278.5 | 289.2 |
| Other long-term assets | 53.5 | 56.8 |
| Total assets | $8,049.7 | $8,119.7 |
| LIABILITIES AND STOCKHOLDERS' EQUITY |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s equity method investments?
- Surgery Partners, Inc. (SGRY) reported equity method investments of $226.9M in Q2 2026.
- How has Surgery Partners, Inc.'s equity method investments changed year-over-year?
- Surgery Partners, Inc.'s equity method investments increased by 3.0% year-over-year, from $220.2M to $226.9M.
- What is the long-term trend for Surgery Partners, Inc.'s equity method investments?
- Over 5 years (2020 to 2025), Surgery Partners, Inc.'s equity method investments has grown at a 21.0% compound annual growth rate (CAGR), from $90.3M to $234M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Surgery Partners, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude